Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2010
03/31/2010CN101686987A Treatment of tardive dyskinesia with pyridoxal 5'-phosphate
03/31/2010CN101686984A Pharmaceutical combination of nsaid and prostaglandin compound
03/31/2010CN101686978A Titration schedule for bifeprunox for treating schizophrenia and kits for use therein
03/31/2010CN101686977A Therapeutic or prophylactic agent for dyskinesia
03/31/2010CN101686970A Synergistic combination of anthranilamide pyridinureas and benzamide derivatives
03/31/2010CN101686947A duloxetine formulation
03/31/2010CN101686945A Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject
03/31/2010CN101686937A Oronasopharyngeally deliverable pharmaceutical composition for the prevention/alleviation and/or treatment of restless limb disorder
03/31/2010CN101686922A a liquid formulation for administering nicotine
03/31/2010CN101686919A Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
03/31/2010CN101684158A Binding domain-immunoglobulin fusion proteins
03/31/2010CN101684155A Nucleotide and protein sequences of nogo genes and methods based thereon
03/31/2010CN101684118A Use of tricyclic compounds as glycine transport inhibitors
03/31/2010CN101684106A Thiazole onium salt compound and application for treating diseases relative to protein aging thereof
03/31/2010CN101684096A Novel benzoazepine compound and preparation method and application thereof
03/31/2010CN101684091A cannabinoid receptor ligands
03/31/2010CN101683520A Methods for treating tweak-related conditions
03/31/2010CN101683513A Preparation method of pill containing angelica, monkshood and cassia twig for dredging meridians
03/31/2010CN101683492A Patch for treating facioplegia and method for producing the same
03/31/2010CN101683474A Traditional Chinese medicine composition for nourishing yin and nourishing blood
03/31/2010CN101683473A Traditional Chinese medicine composition for regulating qi and dispelling wind
03/31/2010CN101683459A Application of a traditional Chinese medicine composition in preparation of medicament for treating sleep disorder
03/31/2010CN101683444A Preparation method of pill containing peony and notopterygium
03/31/2010CN101683434A Preparation method of powder for eliminating blood stasis, expelling wind and relieving pain
03/31/2010CN101683433A Preparation method of nourishing ointment containing sweet wheat and jujubes
03/31/2010CN101683432A Preparation method of pill for removing blood stasis and relieving pain
03/31/2010CN101683431A Preparation method of pill for strengthening spleen and nourishing kidney
03/31/2010CN101683410A Preparation method of cake for warming channels and activating collaterals
03/31/2010CN101683407A Traditional Chinese medicine compound preparation for treating insomnia and preparation method thereof
03/31/2010CN101683401A Preparation method of Yusheng powder containing monkshood
03/31/2010CN101683383A Preparation method of pill containing angelica and notopterygium
03/31/2010CN101683348A Application of cholestane-3 beta, 5 alpha, 6 beta-triol in preparation of neuronal protection medicine
03/31/2010CN101683343A Method of using (2-imidazolin-2-ylamino) quinoxalines in treating neural injury
03/31/2010CN101683342A Methylphenidatefrozen dry powder preparation for injection and preparation process thereof
03/31/2010CN101683334A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
03/31/2010CN101683157A Prescription and process for producing inebriation relieving and stomach nourishing tea
03/31/2010CN100596299C Dehydrosilibinin diester derivatives, preparation method and use thereof
03/31/2010CN100596297C Technology for extracting dihydrogalanthamine from lycoris radiata genus plant
03/31/2010CN100596276C Slow-released vincamine capsule and its preparation process
03/30/2010US7687664 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it
03/30/2010US7687640 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde; inhibits production of A beta 40 and A beta 42 from amyloid precursor protein ; Alzheimer's disease and Down syndrome
03/30/2010US7687620 [1,4]diazepino[6,7,1-IJ]quinoline derivatives as antipsychotic and antiobesity agents
03/30/2010US7687606 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil.
03/30/2010US7687536 Aminocycloalkyl cinnamide compounds for arrhythmia and as analgesics and anesthetics
03/30/2010US7687518 4-Tetrazolyl-4-phenylpiperidine compounds for prophylaxis and therapy of pain or diarrhea in an animal
03/30/2010US7687514 Benzimidazole derivatives
03/30/2010US7687512 Use of pyridinyl-pyrimidinylamino-benzamide derivatives for the treatment of amyloid related disorders
03/30/2010US7687507 Protein tyrosine kinase, such as Janus Kinase 3, inhibitors, immunosuppressants; organ transplants, lupus, multiple sclerosis, psoriasis; antidiabetic agents, antiarthritic agents, anticarcinogenic agents, Alzheimer's Disease, Crohn's Disease, Inflammatory Bowel Disease, autoimmune thyroid disorders
03/30/2010US7687505 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
03/30/2010US7687502 Substituted quinazoline or pyridopyrimidine derivative
03/30/2010US7687501 fused tricyclic compounds useful as metabotropic glutamate receptor (mGluR) antagonists, particularly as selective metabotropic glutamate receptor 1 antagonists
03/30/2010US7687485 Formulation for menopausal women
03/30/2010US7687483 Phosphorus compounds used for improving permeability of drugs such as anticarcinogenic agents to biological barriers; drug delivery
03/30/2010US7687457 Cyclic molecular framework and derivatives thereof
03/30/2010US7687059 Systems and methods for treating patients with processed lipoaspirate cells
03/30/2010CA2572508C One pot synthesis of 2-oxazolidinone derivatives
03/30/2010CA2457444C 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
03/30/2010CA2442245C 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity
03/30/2010CA2405971C New piperazine and piperidine compounds
03/30/2010CA2396049C A health food product comprising a pungent substance
03/30/2010CA2395789C Methods of detection of amyloidogenic proteins
03/30/2010CA2389306C Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
03/30/2010CA2380673C Compositions comprising modafinil for treatment of attention deficit hyperactivity disorder
03/30/2010CA2374755C Mono- and disubstituted 3-propyl gamma-aminobutyric acids
03/30/2010CA2374044C Sports drink comprising lactobacilli
03/30/2010CA2362277C Spontaneously dispersible n-benzoyl staurosporine compositions
03/30/2010CA2355860C Dosage forms comprising porous particles
03/30/2010CA2306429C Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5t h1a receptors
03/30/2010CA2176183C 3-substituted oxindole derivatives as potassium channel modulators
03/30/2010CA2171207C Methods for regulating gastrointestinal motility
03/25/2010WO2010033890A1 Polymorphs of 6-beta-naltrexol
03/25/2010WO2010033824A1 Sulfonamide derivatives as inhibitors of ion channels
03/25/2010WO2010033451A2 5-oxazolidin-2-one substituted 1,3,8-triazaspiro [4.5] decan-4-one derivatives useful as orl-1 receptor modulators
03/25/2010WO2010033292A2 Method for medical treatment utilizing l-glutathione
03/25/2010WO2010033270A1 Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
03/25/2010WO2010033195A1 Pegylated opioids with low potential for abuse
03/25/2010WO2010033168A2 Amide compounds, compositions and uses thereof
03/25/2010WO2010033045A1 Compositions and methods for prevention or treatment of beta amyloid deposition
03/25/2010WO2010032856A1 Nitrogen-containing heterocyclic compound and use of same
03/25/2010WO2010032731A1 Benzimidazole compound in crystal form and salt thereof
03/25/2010WO2010032257A1 Aryl indolyl sulfonamide compounds and their use as 5-ht6 ligands
03/25/2010WO2010032123A1 Triterpenoid compounds and methods of use thereof
03/25/2010WO2010031735A1 Piperazine d3 and 5-ht2a receptor modulators
03/25/2010WO2010031346A1 Freeze-dried preparation of tetrodotoxin and the producing method thereof
03/25/2010WO2010031248A1 Thiazolium salt compound and the use of treating the protein aging disease
03/25/2010WO2010031114A1 Novel receptor hetero-dimers/-oligomers
03/25/2010WO2010011367A3 Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using
03/25/2010WO2010011117A3 Ndga-containing composition for the suppression of transglutaminase
03/25/2010WO2010008777A3 Fused azabicyclic pyridines
03/25/2010WO2010008735A9 Solid states of o-desmethylvenlaf axine salts
03/25/2010WO2010003084A3 Phosphodiesterase 4 inhibitors
03/25/2010WO2009158447A9 Materials and methods for suppressing and/or treating neurofibroma and related tumors
03/25/2010WO2009158387A3 Compositions, formulations, and methods for preventing and/or treating physical effects of alcohol consumption
03/25/2010WO2009148287A3 Novel α-iso-cubebene compound extracted from schisandra chinensis and composition containing the compound as active ingredient for preventing and treating inflammatory diseases
03/25/2010WO2009145814A3 Pyrimidines and pyridines useful as inhibitors of protein kinases
03/25/2010WO2009141533A3 Pyrrole derivatives, preparation of same and therapeutic application thereof as cannabinoid cb1 receptor antagonists
03/25/2010WO2009122351A3 Anti-parkinsonian compounds mppe
03/25/2010WO2009121759A3 Use of pegylated igf-i variants for the treatment of neuromuscular disorders
03/25/2010WO2008157460A8 Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties
03/25/2010US20100077498 Compositions and methods for blood-brain barrier delivery in the mouse
1 ... 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 ... 1833